Gallium-68 PSMA-R2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gallium-68 PSMA-R2, covering 2024-01-30 to 2024-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer [Phase 2]